UC Davis Opened Translational Brain Tumor Center
The new facility integrates veterinary and human medicine to accelerate brain cancer treatment research.
Updated on Sept. 29, 2026 in Veterinary Medicine
Live Poll
Should medical research prioritize developing shared cancer treatments for both people and pets?
UC Davis has launched the Translational Brain Tumor Center to bridge the gap between scientific discovery and clinical application. The facility brings together the university’s veterinary and human medical schools to advance the study of brain cancers.
Why it matters
By merging veterinary clinical trials with human medicine, the center aims to shorten the timeline for moving laboratory research into patient treatments. This collaborative approach utilizes veterinary insights to improve outcomes for both animals and humans facing brain tumors.
The center is a collaborative initiative connecting the UC Davis Weill School of Veterinary Medicine and UC Davis Health. It focuses on integrating laboratory research with veterinary clinical trials to bridge the path to human medicine.
The players
UC Davis Weill School of Veterinary Medicine
This institution is a component of the new center and leads research efforts in animal health and veterinary clinical trials.
UC Davis Health
This academic health system partners with the veterinary school to apply laboratory findings to human brain cancer treatment.
The details
The facility operates by combining expertise from both the veterinary and human health sectors to study complex brain cancers. It emphasizes a cross-disciplinary workflow that utilizes veterinary clinical data to expedite progress in medical treatments.
Timeline
The UC Davis Translational Brain Tumor Center opened in September 2026.
The Big Picture
The center follows the One Health approach, which recognizes the interconnectedness of human and animal health. This marks a strategic shift from siloed research models to a collaborative framework that leverages animal data to solve human medical problems.
Residents in Davis will benefit from the increased local presence of advanced clinical trials focusing on neuro-oncology. This research model could ultimately provide pet owners and human patients with faster access to novel diagnostic tools and emerging treatment options.
The takeaway
This interdisciplinary model demonstrates how biological similarities between species can be exploited to accelerate life-saving medical discoveries. By fostering such partnerships, researchers can significantly reduce the time and cost required to develop effective therapies.
Further reading
Learn more about the latest innovations in Veterinary Medicine at the university.
Source note: This article includes information reported by Davis Enterprise.
Live Poll
Should medical research prioritize developing shared cancer treatments for both people and pets?
